返回 Agenda
Session Chair(s)
Martine Dehlinger-Kremer, PHD
Sn Drug Development Strategy Lead Pediatrics
UCB Biosciences, Germany
Learning Objective : Under the Paediatric Regulation, clinical research in children is becoming part of drug development. For successful studies in children, the design of the clinical trials is key. Attendees will be provided with Important aspects to be considered for the preparation of protocols suitable for studies in children.
Speaker(s)
Considerations for the Design of Clinical Trials in Children
Martine Dehlinger-Kremer, PHD
UCB Biosciences, Germany
Sn Drug Development Strategy Lead Pediatrics
Overcoming the Challenges of Recruiting Pediatric Patients
Sylvie Jouve, PHD
Premier Research Group, France
Pediatric Clinical Research Senior Project Manager,
eDiaries for Clinical Trials – An example of recruiting paediatric patients
Valdo Arnera, DrMed, MD
Clario, Switzerland
Medical Advisor